Privia Health Group, INC

Privia Health Group, Inc. announced the immediate resignation of director Shawn Morris from its Board and Compliance Committee, effective July 6, 2026.

Privia Health Group stockholders approved the election of three directors, executive compensation, and the appointment of auditors at the 2026 Annual Meeting.

Privia Health Group, Inc. announced robust first quarter 2026 financial results, exceeding expectations with significant growth in revenue and key operating metrics, while reiterating full-year guidance.

Privia Health Group, Inc. reported full-year 2025 financial results exceeding all guidance ranges and provided an optimistic outlook for 2026 with projected Adjusted EBITDA growth.

Privia Health Group, Inc. announced the successful closing of its acquisition of an Accountable Care Organization business from Evolent Health, Inc.

Privia Health Group, Inc. reported very strong third quarter and year-to-date 2025 financial results, with significant growth in net income and adjusted EBITDA, leading to an upward revision of its full-year guidance.

Privia Health Group, Inc. has amended its credit agreement to increase the revolving credit commitment and extend the maturity date.

Privia Health Group, Inc. announced robust financial results for the third quarter and first nine months of 2025, driven by significant revenue increases, expanded provider network, and strategic acquisitions.

Privia Health Group, Inc. announced significant revenue growth and expansion into new markets, alongside increased key operational metrics, despite a quarterly dip in GAAP net income.

Privia Health Group's Q1 2025 shows revenue growth driven by new providers, increased patient volume, and expansion in value-based care.

Privia Health Group's third quarter 2024 results show a 4.9% increase in revenue compared to the same period last year, driven by growth in fee-for-service and value-based care programs.

Privia Health Group's second quarter results show a slight revenue increase but a decrease in net income, reflecting strategic adjustments in value-based care contracts.

Privia Health Group, Inc. announced significant financial and operational growth for the year ended December 31, 2025, driven by increased provider base and value-based care expansion.

Privia Health Group's 2024 10-K filing reveals continued growth driven by provider expansion and value-based care initiatives, alongside strategic investments in technology and new markets.

Privia Health Group, Inc. reports a revenue of approximately $1.66 billion for the year ended December 31, 2023, alongside strategic expansions and a focus on value-based care.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., sold 21,275 shares of common stock on July 9, 2026 for $27.67 per share.

Privia Health Group, Inc. EVP & Chief Financial Officer David Mountcastle reported a sale of 600 shares of common stock, executed under a pre-arranged 10b5-1 trading plan.

Privia Health Group, Inc. Director Matthew Shawn Morris executed trades under a pre-arranged 10b5-1 plan, selling a significant number of shares and exercising stock options.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., reported the sale of 24,734 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Privia Health Group, Inc. Director Matthew Shawn Morris executed trades under a Rule 10b5-1 plan, involving the acquisition and disposition of common stock and stock options.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., reported transactions involving the sale of common stock and the exercise of stock options under a pre-arranged Rule 10b5-1 trading plan.

Privia Health addresses concerns raised by Institutional Shareholder Services (ISS) regarding its classified board structure, reaffirming its intention to evaluate the board's feasibility on an ongoing basis.

Privia Health Group will hold its annual stockholders meeting on May 21, 2025, to elect directors, approve executive compensation, and ratify the appointment of its accounting firm.

Privia Health Group announces its 2025 Annual Meeting of Stockholders to be held virtually on May 21, 2025, featuring director elections, executive compensation advisory vote, and ratification of the independent accounting firm.

Privia Health Group will hold its annual stockholders meeting on May 22, 2024, to elect directors, approve executive compensation, ratify the appointment of PricewaterhouseCoopers LLP, and vote on amendments to the company's charter.

Privia Health Group will hold its 2024 Annual Meeting of Stockholders virtually on May 22, 2024, to vote on director elections, executive compensation, auditor ratification, and charter amendments.

Vanguard Portfolio Management has reported beneficial ownership of 5.16% of Privia Health Group Inc.'s common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Privia Health Group Inc. following an internal corporate realignment.

FMR LLC and Abigail P. Johnson have reported an aggregate beneficial ownership of 10.1% of Privia Health Group Inc.'s common stock as of September 30, 2025.

A group of entities including Puma Growth Holdings and Rubicon Founders, led by Adam Boehler, reported a 4.7% beneficial ownership stake in Privia Health Group, Inc.

Rubicon Founders and affiliated entities have disclosed a 5.14% passive ownership stake in Privia Health Group, Inc., totaling 6,278,522 common shares.

FMR LLC and its affiliates, including Abigail P. Johnson, reported beneficial ownership of 11.4% of Privia Health Group Inc.'s common stock as of June 30, 2025.